Clinical Trial Update: Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a quadruple combination of daratumumab, carfilzomib, pomalidomide, and dexamethasone for multiple myeloma; study is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Carfilzomib (carfilzomib)
• DEXAMETHASONE (Dexamethasone)
• Daratumumab (daratumumab)
• Pomalidomide (Pomalidomide)

Snippet

Sponsor: Andrew Yee, MD | Conditions: Multiple Myeloma, Refractory Multiple Myeloma | Phase 2 | Status: RECRUITING